Tropic Biosciences
Evolving Agriculture. Sustaining People & Planet.
Norwich, United Kingdom · Founded 2016 · $143.5M raised
- Headquarters
- Norwich
- Employees
- 51–200
- Founded
- 2016
- Business Model
- B2B
- Website
- tropic.bio
- Total Funding
- $143.5M
- Last Round
- $105.0M Venture RoundMar 2026
- Rounds
- 3
About
Tropic (formerly Tropic Biosciences) is a UK-based agricultural biotechnology company that uses cutting-edge gene editing techniques to develop high-performance varieties of tropical commodity crops. Their proprietary GEiGS® (Gene Editing induced Gene Silencing) platform combines the precision of gene editing with the versatility of gene silencing (RNAi). The company focuses on improving crop resistance to critical diseases, reducing pesticide reliance, and improving supply chain sustainability — primarily for banana, coffee, and rice growers across the tropics.
Summary
Tropic Biosciences is a Healthcare company based in Norwich, United Kingdom, founded in 2016. It has raised $143.5M in total across 3 rounds, most recently a $105.0M Venture Round round in Mar 2026. Investors include Five Seasons Ventures, Corteva and Temasek.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Mar 2026
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...